| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Apr 2, 2019Virtual Press Office and PR Newswire: General Trade show news
MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced that Daniel P. Gold, Ph.D., president and chief executive...
-
Apr 2, 2019Virtual Press Office and PR Newswire: General Trade show news
OncoSec Medical Incorporated (OncoSec) (NASDAQ: ONCS), a company developing novel cancer immunotherapies, today presented pre-clinical data highlighting its novel anti-tumor product candidate,...
-
Apr 2, 2019Virtual Press Office and PR Newswire: General Trade show news
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) announced today the company's novel DNA-Encoded Bi-specific T Cell Engagers (dBiTEs™) generated potent anti-tumor activities in a preclinical study....
-
Apr 2, 2019Virtual Press Office and PR Newswire: General Trade show news
Researchers from Invitae (NYSE: NVTA), a leading genetics company, will present data from more than 113,000 patients that support updating genetic testing guidelines to include clear...
-
Apr 2, 2019Virtual Press Office and PR Newswire: General Trade show news
Today at AMUG 2019, privately held Dyndrite Corporation announced that Gradient Ventures, Google's AI-focused investment fund and an early Dyndrite investor, will lead the company's $10+ million...
